News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Rajesh Rai: Cutting-edge app designed to simplify your access to the latest drugs, research, and critical information needed for effective cancer treatment
Sep 2, 2024, 15:20

Rajesh Rai: Cutting-edge app designed to simplify your access to the latest drugs, research, and critical information needed for effective cancer treatment

Rajesh Rai, Co-Founder of Oncowise AI, shared on LinkedIn:

“Hi Oncology Friends,

We’re thrilled to introduce a cutting-edge app designed to simplify your access to the latest drugs, research, and critical information needed for effective cancer treatment.

Access the app here.

For a limited time, we’re offering exclusive free access to a select group of oncology experts. We’d love to hear your feedback on how this tool enhances your daily practice.

Together, let’s advance cancer care and improve patient outcomes.”

Rajesh Rai: Cutting-edge app designed to simplify your access to the latest drugs, research, and critical information needed for effective cancer treatment

Source: Rajesh Rai/LinkedIn

cancer cancer care cancer innovations Cancer research cancer treatment Drug Access LinkedIn OncoDaily Oncology oncology app Oncology Experts oncology technology Oncowise AI patient outcomes Rajesh Rai
Special Coverage
Blog
Dec 22, 2024, 04:58
Summary slide for PFS in selected trials by IGHV status caveat for CLL by Nitin Jain
Insight
Dec 22, 2024, 04:53
Cancer survivors are growing in number - National Cancer Institute
Blog
Dec 22, 2024, 04:52
Registration is open for the ESMO Gastrointestinal Cancers Congress 2025
Blog
Dec 22, 2024, 04:49
Amalya Sargsyan: New ESO Rare Cancer Series podcast with Salvatore Provenzano
Insight
Dec 22, 2024, 04:47
Journal of Psychosocial Oncology Research and Practice: Vol. 6, Number 4 - IPOS
Science
Dec 22, 2024, 04:40
The prevalence of widespread guideline-discordant LDCT screening in a low-risk population by So Yeon Kim et al.
Blog
Dec 22, 2024, 04:38
The new Institute of Cancer Research spinout company Sentinal4D has been announced to the public
Blog
Dec 22, 2024, 04:34
Nermean Mostafa: Honored to co-organize women cancer patient advocacy session hosted by 8th Gyne-Oncology conference
Blog
Dec 22, 2024, 04:24
Jordan Rathkopf: As 2024 winds down, we’ve been reflecting on what a year it’s been
Insight
Dec 22, 2024, 00:21
Eric J. Small: ASCO/Conquer Cancer Foundation Felix Feng Prostate Cancer YIA is now fully endowed
Blog
Dec 21, 2024, 22:40
50 Years of History, a Future to Write Together - AIEOP
Science
Dec 21, 2024, 22:37
Breaking Down the Impact of Ionizing Radiation on Cancer